D-0700-2017 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- May 17, 2017
- Initiation Date
- March 22, 2017
- Termination Date
- July 11, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,138 bottles
Product Description
Olanzapine Tablets, 7.5 mg, packaged in a) 30-count bottles (NDC 62756-553-83), b) 100-count bottles (NDC 62756-553-88), and c) 1000-count bottles (NDC 62756-553-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India.
Reason for Recall
Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).
Distribution Pattern
Nationwide in the USA and Puerto Rico
Code Information
Lot #: a) JKP3150B, Exp 06/17, JKR5749A, Exp 06/18; b) JKP2757A, Exp 05/17, JKP3149A, JKP3150A, Exp 06/17, JKR5049A, Exp 04/18; c) JKP2758B, Exp 05/17